Kingstone Capital Partners Texas, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Kingstone Capital Partners Texas, LLC
- $624 Billion
- Q2 2025
A detailed history of Kingstone Capital Partners Texas, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Kingstone Capital Partners Texas, LLC holds 77,592 shares of REGN stock, worth $43.2 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
77,592Holding current value
$43.2 Million% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,396Shares Held
87.6MCall Options Held
1.38MPut Options Held
1.37M-
Vanguard Group Inc Valley Forge, PA9.42MShares$5.24 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.7 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$3.15 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.83MShares$2.69 Billion0.1% of portfolio
-
Dodge & Cox San Francisco, CA3.83MShares$2.13 Billion1.21% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $59.7B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...